Related Experiment Video
Updated: Sep 16, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Incidence of multiple sclerosis (MS) relapse after COVID-19 infection: A systematic review and meta-analysis
Amin Momeni Moghaddam1, Mohsen Rastkar2, Atena Soltanzadi1
1Department of Radiology, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Background:
COVID-19 could exacerbate the symptoms of autoimmune diseases such as multiple sclerosis (MS). Literature shows an increase in the incidence of relapse in patients with MS after COVID-19. We designed this systematic review and meta-analysis to estimate the pooled incidence of MS-relapse after COVID-19.
Methods:
We performed a systematic search in PubMed, Scopus, EMBASE, Web of Science, and Google scholar. Gray literature including references of the references and conference abstracts were also searched to find relevant articles. We extracted data regarding the total number of participants, the name of the first author, publication year, country of origin, mean age, mean disease duration, mean Expanded Disability Status Scale (EDSS), and the number of patients with relapse after COVID.
Results:
A literature search revealed 5160 articles, after deleting duplicates, 2270 remained. After careful evaluation of the full texts, twelve studies were included for meta-analysis. Totally, 1595 patients with MS who had a history of COVID-19 were evaluated. Most studies were done in Iran. The mean age of included patients ranged between 35 and 49 years, and mean durations of the disease were between 7and 15.4 years. The incidence of relapse ranged between 2% and 20% in included studies.The pooled incidence of relapse after COVID-19 was 7% (95%CI:5-10%) (I2=64%, p<0.001).
Conclusions:
The results of this systematic review and meta-analysis show that the pooled incidence of MS-related relapse after COVID-19 is 7%.
Insights
COVID-19 can worsen multiple sclerosis (MS) symptoms. This review found a 7% pooled incidence of MS relapse after COVID-19 infection, highlighting the need for careful monitoring in these patients.
Area of Science:
- Neurology
- Immunology
- Infectious Diseases
Background:
- COVID-19 is known to potentially exacerbate autoimmune conditions.
- Existing literature indicates an increased risk of relapse in multiple sclerosis (MS) patients post-COVID-19 infection.
Purpose of the Study:
- To estimate the pooled incidence of multiple sclerosis (MS) relapse following COVID-19 infection.
- To synthesize current evidence on the impact of COVID-19 on MS disease activity.
Main Methods:
- A systematic review and meta-analysis was conducted.
- Searches were performed across major databases (PubMed, Scopus, EMBASE, Web of Science, Google Scholar) and gray literature.
- Data from 12 studies involving 1595 MS patients with a history of COVID-19 were analyzed.
Main Results:
- The pooled incidence of MS relapse after COVID-19 was calculated to be 7% (95% CI: 5-10%).
- Relapse incidence varied between 2% and 20% across the included studies.
- The analysis included data from studies primarily conducted in Iran, with patient ages ranging from 35-49 years.
Conclusions:
- COVID-19 infection is associated with a 7% pooled incidence of relapse in patients with multiple sclerosis.
- These findings underscore the importance of monitoring MS patients for disease activity after SARS-CoV-2 infection.
More Related Videos
Related Concept Videos
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Myocarditis III: Medical Management
Stages of Infection

